Antiplatelet therapy in children: why so different from adults'?

Author: BassareoPier Paolo, FanosVassilios, IacovidouNicoletta, MercuroGiuseppe

Paper Details 
Original Abstract of the Article :
Antiplatelet agents are administered in the treatment of a large number of adult diseases: coronary heart disease, ischemic stroke, peripheral arterial disease, arrhythmias with their thromboembolic complications, primary and secondary prevention. In childhood however, the situation is substantially...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.2174/1381612811209023019

データ提供:米国国立医学図書館(NLM)

Navigating the Desert of Pediatric Antiplatelet Therapy

Antiplatelet agents, medications that prevent blood clots, are like oases in the desert of cardiovascular disease, offering protection against heart attacks and strokes. However, the use of these drugs in children presents unique challenges, as research in this area is limited. This research explores the current state of knowledge regarding antiplatelet therapy in children, highlighting the need for more research to guide clinical practice.

A Desert of Data: Limited Research on Antiplatelet Therapy in Children

This research underscores the lack of comprehensive data on the use of antiplatelet agents in children. It's like navigating a desert with limited information about the terrain – more research is needed to guide safe and effective use of these drugs in this population.

The Importance of Evidence-Based Care in Pediatric Antiplatelet Therapy

This research highlights the importance of evidence-based care in pediatric antiplatelet therapy. It's like ensuring that every traveler in the desert has a reliable map and compass – rigorous research and clear guidelines are essential for making informed decisions about the use of these drugs in children.

Dr. Camel's Conclusion

This research emphasizes the crucial need for more research on antiplatelet therapy in children. It reminds us that the desert of pediatric care is vast and requires a dedicated effort to ensure that every child receives the best possible treatment.

Date :
  1. Date Completed 2012-12-27
  2. Date Revised 2019-07-28
Further Info :

Pubmed ID

22564296

DOI: Digital Object Identifier

10.2174/1381612811209023019

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.